By Chibuike Oguh NEW YORK (Reuters) – U.S. stocks ended lower on Tuesday as markets weighed economic data showing rising labor costs and deteriorating consumer confidence on the day of a key Fed[...]
Read more
April 30, 2024
Starbucks cuts annual sales forecast as demand cools in key US, China markets
By Juveria Tabassum (Reuters) -Starbucks on Tuesday cut its annual sales forecast after reporting a fall in same-store sales for the first time in nearly three years, as it struggles with weak demand[...]
Read more
Warren Buffett’s PacifiCorp faces $30 billion of new wildfire claims
By Jonathan Stempel (Reuters) -A utility owned by Warren Buffett’s Berkshire Hathaway faces $30 billion of new claims blaming it for causing Oregon wildfires in 2020, nearly four times the maxim[...]
Read more
Pinterest forecasts quarterly revenue above estimates, shares surge
By Jaspreet Singh (Reuters) -Pinterest forecast second-quarter revenue above Wall Street estimates on Tuesday, expecting a boost from its ad partnerships with Amazon and Google, sending shares up more[...]
Read more
Trump social media firm’s rising shares pressure short-sellers, S3 says
By David Randall NEW YORK (Reuters) – Short-sellers in Trump Media & Technology Group are feeling the heat from the recent rally in the company’s stock and the higher cost of borrowing[...]
Read more
Caesars Entertainment misses quarterly estimates on Las Vegas business hit
(Reuters) – Caesars Entertainment missed market expectations for first-quarter results on Tuesday, as record levels of occupancy driven by the Super Bowl and visits for the Chinese New Year were[...]
Read more
GM in talks with Barclays to replace Goldman Sachs in credit card partnership -source
NEW YORK (Reuters) -General Motors is in talks with Barclays for a credit card partnership deal that will replace existing partner Goldman Sachs, a source familiar with the matter told Reuters. Goldma[...]
Read more
Weight-loss drug drives Eli Lilly to raise 2024 sales forecast by $2 billion
By Bhanvi Satija and Patrick Wingrove (Reuters) -Explosive demand and increased manufacturing capacity for Eli Lilly’s weight-loss drug Zepbound drove the company to raise its annual sales forec[...]
Read more
Pot stocks jump as U.S. DOJ moves to reclassify cannabis as a less dangerous drug
By Tanay Dhumal (Reuters) -Shares of cannabis companies surged on Tuesday afternoon after the U.S. Department of Justice (DoJ) moved to reclassify marijuana as a less dangerous drug. U.S.-listed share[...]
Read more